Lisdexamfetamine 60 mg capsules failed dissolution testing at nine month stability
Lisdexamfetamine Dimesylate Capsules 60 mg are being recalled because an out of specification result was observed in dissolution testing at the nine month long term stability station. 5,448 bottles affected.
- Product
- LISDEXAMFETAMINE DIMESYLATE — LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)
- Category
- Drug
- Distribution
- Distributed nationwide